Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimme L Hyrich

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Seminars in Arthritis and Rheumatism|November 30, 2019
Real world data in rheumatologyKimme L Hyrich
BMJ (Clinical Research Ed.)|January 26, 2008
Patients with suspected rheumatoid arthritis should be referred early to rheumatologyKimme L Hyrich
The Journal of Rheumatology. Supplement|January 22, 2005
Assessing the safety of biologic therapies in rheumatoid arthritis: the challenges of study designKimme L Hyrich
Annals of the Rheumatic Diseases|September 14, 2022
EULAR 75-year anniversary: commentaries on <i>ARD</i> papers from 25 years agoKimme L Hyrich
Nature Clinical Practice. Rheumatology|October 15, 2008
Are patients with RA at increased risk of malignancy?Kimme L Hyrich
Expert Review of Clinical Immunology|September 16, 2021
How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studiesKim Lauper, Kimme L Hyrich
Annals of the Rheumatic Diseases|February 8, 2024
Annals of the Rheumatic Diseases collection on pregnancy 2018-2023: observational data-driven knowledgeKate Duhig, Kimme L Hyrich
Expert Review of Clinical Immunology|March 7, 2012
Abatacept in the long-term treatment of rheumatoid arthritisMeghna Jani, Kimme L Hyrich
Rheumatology (Oxford, England)|December 14, 2019
What can rheumatology expect from real-world data?Kimme L Hyrich, Angela Zink
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 4, 2009
Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of responseLaura J Gibbons, Kimme L Hyrich
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Seminars in Arthritis and Rheumatism|November 30, 2019
Real world data in rheumatologyKimme L Hyrich
BMJ (Clinical Research Ed.)|January 26, 2008
Patients with suspected rheumatoid arthritis should be referred early to rheumatologyKimme L Hyrich
The Journal of Rheumatology. Supplement|January 22, 2005
Assessing the safety of biologic therapies in rheumatoid arthritis: the challenges of study designKimme L Hyrich
Annals of the Rheumatic Diseases|September 14, 2022
EULAR 75-year anniversary: commentaries on <i>ARD</i> papers from 25 years agoKimme L Hyrich
Nature Clinical Practice. Rheumatology|October 15, 2008
Are patients with RA at increased risk of malignancy?Kimme L Hyrich
Expert Review of Clinical Immunology|September 16, 2021
How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studiesKim Lauper, Kimme L Hyrich
Annals of the Rheumatic Diseases|February 8, 2024
Annals of the Rheumatic Diseases collection on pregnancy 2018-2023: observational data-driven knowledgeKate Duhig, Kimme L Hyrich
Expert Review of Clinical Immunology|March 7, 2012
Abatacept in the long-term treatment of rheumatoid arthritisMeghna Jani, Kimme L Hyrich
Rheumatology (Oxford, England)|December 14, 2019
What can rheumatology expect from real-world data?Kimme L Hyrich, Angela Zink
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 4, 2009
Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of responseLaura J Gibbons, Kimme L Hyrich
Pageof 25